ArticleClinical pharmacokinetics2020

Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?

Didier Concordet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.